Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

DATA-2000 Certified Physicians:

NAABT downloads the data for the locator from SAMHSA, thus is unable to edit the list ourselves. However, virtually all web sites that have the locator do the same, so once your information is correct on the SAMHSA master list, it will soon be on all others including this one.

Physicians already listed on the locator but want to add a location, edit, or delete their listing, can now do that themselves.
Click this link for instructions:
http://buprenorphine.samhsa.gov/pls/bwns/updtcntct2$.startup

If not already listed, waived physicians may call 1-866-BUP-CSAT (1-866-287-2728) or e-mail info@buprenorphine.samhsa.gov with requests to be added to the Locator listings.

Important note:

The Drug Enforcement Administration must also be notified when a waived physician changes the primary practice address at which they intend to treat opioid addiction under the authority of their DATA 2000 waiver. Call the DEA Office of Diversion Control at 1-800-882-9539. DEA FAQ.

Phone numbers for local DEA offices can be found on the DEA Web site at http://www.usdoj.gov/dea/contactinfo.htm

DEA online address change form: http://www.deadiversion.usdoj.gov/drugreg/change_requests/addchange.pdf

Important information about this list

 

<< Back to previous page >>Go to Physician search
This page was last modified on : 10/24/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.